Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: A Canadian Blood Services Stem Cell Registry analysis.
David S AllanMeagan GreenGail MorrisJason WeissNicholas DibdinDena MercerMatthew SeftelPublished in: Vox sanguinis (2022)
Demand for unrelated adult HCT donors has remained stable despite the evolving pandemic with a transient and recurring increased interest and usage of domestic adult donors. Use of CBUs for paediatric patients has increased and remains elevated. Registries and donor collection centres should maintain the capacity to expand services for domestic donor collection during pandemics to offset threats to international donor usage.
Keyphrases
- stem cells
- healthcare
- primary care
- end stage renal disease
- cell therapy
- newly diagnosed
- mental health
- stem cell transplantation
- ejection fraction
- emergency department
- coronavirus disease
- peritoneal dialysis
- single cell
- mesenchymal stem cells
- brain injury
- blood brain barrier
- cerebral ischemia
- cell proliferation
- affordable care act
- signaling pathway
- cell death
- data analysis
- subarachnoid hemorrhage
- childhood cancer